Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NovoMedix
AddedFeb 16, 2024
UpdatedJun 18, 2026
NovoMedix

NovoMedix

NovoMedix develops novel molecules for fibrotic disorders and cancer treatment, aiming to enhance efficacy while reducing cardiotoxicity.

HQ
San Diego, CA, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, NovoMedix is a biotechnology company dedicated to developing novel, orally available small molecules aimed at treating fibrotic disorders and certain cancers. The company's core mission is to create therapies that enhance efficacy while minimizing cardiotoxicity. NovoMedix's innovative molecules co-target pathways that offer cardioprotective and synergistic anti-tumor effects, particularly for triple negative breast cancer (TNBC), alongside standard chemotherapies.

Notable affiliates include presentations at significant scientific forums like the American Heart Association (AHA) Scientific Sessions. NovoMedix has garnered attention for its preclinical data on NMX2, showcasing promising therapeutic potential. The company’s achievements in developing first-in-class small molecules have positioned it as a key player in both fibrosis and oncology research, contributing to advancements in medical treatments with a focus on improving patient outcomes.

NovoMedix - Similar Companies

Novo Biosciences logo

Novo Biosciences

MediciNova logo

MediciNova

medicinova.com

NovelMed Therapeutics logo

NovelMed Therapeutics

novelmed.com

Novopyxis logo

Novopyxis

novopyxis.com

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

NovoThelium logo

NovoThelium

novothelium.com

Novelix Pharmaceuticals logo

Novelix Pharmaceuticals

Noveome Biotherapeutics logo

Noveome Biotherapeutics

noveome.com

Medinox logo

Medinox

medinox.com

Intellimedix logo

Intellimedix

Novita Therapeutics logo

Novita Therapeutics

FibrosIX logo

FibrosIX

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Nurix logo

Nurix

nurixtx.com

Nirogy Therapeutics logo

Nirogy Therapeutics

NovoMedix - Quick Facts

Who are NovoMedix's competitors?

Companies similar to NovoMedix include Novo Biosciences, MediciNova, NovelMed Therapeutics and Novopyxis.

When was NovoMedix founded?

NovoMedix was founded in 2001.

Where is NovoMedix's headquarters located?

NovoMedix's headquarters is located in San Diego, CA, US.

When was NovoMedix's last funding round?

NovoMedix's most recent funding round was for $2M (USD) in May 2022.

How much has NovoMedix raised to-date?

As of May 26, 2022, NovoMedix has raised a total of $2M (USD).

How many employees does NovoMedix have?

NovoMedix has 5 employees as of Feb 4, 2024.

NovoMedix - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified